Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Sandhoff disease

Endocrine, Nutritional and Metabolic Diseases

Sandhoff disease is a rare inherited lysosomal storage disorder in which the body cannot make working copies of the enzymes beta-hexosaminidase A and B. Without them, the fatty compound GM2 ganglioside and related molecules build up in nerve cells and gradually destroy the central nervous system, with death as the eventual outcome. The condition is passed on in an autosomal recessive pattern, so a child is affected only when both parents carry the mutated gene. It is clinically almost indistinguishable from Tay-Sachs disease. Three forms are recognized by the age at which symptoms first appear: classic infantile, juvenile and adult late onset, the infantile form being the most severe. The source article dates the disease to 1968.

Facts
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Classification
Body System
Nervous System 1
First Described
1968 1
Sources
1. Sandhoff disease (Wikipedia)
  • Lead paragraph
    progressive destruction of the central nervous system
  • Lead paragraph [causative-agent-category]
    caused by the inherited deficiency to create functional beta-hexosaminidases A and B
  • Mutations and polymorphism
    Since Sandhoff disease was only discovered in 1968
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.